Clinical Trial Update: Pilot Study to Compare the Pharmacokinetics Parameters in Plasma and Intracellular of Raltegravir Administered Once a Day in Adult Patients Infected With HIV [Phase 4]

View source ↗

Summary

Phase 4 trial update studying pharmacokinetics of raltegravir given once daily in adults with HIV, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Raltegravir (raltegravir)

Snippet

Sponsor: Germans Trias i Pujol Hospital | Conditions: HIV Infections | Phase 4 | Status: COMPLETED